However, taking into account the menopausal status of the patients, in the group of premenopausal patients, PDGF-AB, PDGF-BB, TGF-α and ANG-2 could be potential biomarkers for the diagnosis of endometrial cancer. This evidence concerns the gene ANGPT2 and endometrial cancer.